DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells

Oncogene

Volumn 35, Issue 50, 2016, Pages 6439-6445

  Rajabi, H ^a   Tagde, A ^a   Alam, M ^a   Bouillez, A ^a   Pitroda, S ^b   Suzuki, Y ^a,c   Kufe, D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c OSAKA POLICE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUC1 C ONCOPROTEIN; NUCLEAR FACTOR KAPPA B P65; ONCOPROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; MUC1 PROTEIN, HUMAN; MUCIN 1; TRANSCRIPTION FACTOR RELA;

ARTICLE; BREAST CANCER CELL LINE; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; MCF-7 CELL LINE; NEOPLASM; PHYSIOLOGY;

DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MCF-7 CELLS; MUCIN-1; NEOPLASMS; TRANSCRIPTION FACTOR RELA;

EID: 84969761321     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.180     Document Type: Article

References (41)

1. Li E, Zhang Y. DNA methylation in mammals. Cold Spring Harb Perspect Biol 2014; 6: a019133.
2. Easwaran H, Tsai HC, Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 2014; 54: 716-727.
3. Ahuja N, Easwaran H, Baylin SB. Harnessing the potential of epigenetic therapy to target solid tumors. J Clin Invest 2014; 124: 56-63.
4. Pradhan S, Bacolla A, Wells RD, Roberts RJ. Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J Biol Chem 1999; 274: 33002-33010.
5. Ko YG, Nishino K, Hattori N, Arai Y, Tanaka S, Shiota K. Stage-by-stage change in DNA methylation status of Dnmt1 locus during mouse early development. J Biol Chem 2005; 280: 9627-9634.
6. Ratnam S, Mertineit C, Ding F, Howell CY, Clarke HJ, Bestor TH et al. Dynamics of Dnmt1 methyltransferase expression and intracellular localization during oogenesis and preimplantation development. Dev Biol 2002; 245: 304-314.
7. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99: 247-257.
8. Liang G, Chan MF, Tomigahara Y, Tsai YC, Gonzales FA, Li E et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol 2002; 22: 480-491.
9. Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, Wang YC. Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. Lung Cancer 2007; 55: 205-213.
10. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y et al. Expression of DNA methyltransferases DNMT1, 3 A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001; 97: 1172-1179.
11. Qu Y, Mu G, Wu Y, Dai X, Zhou F, Xu X et al. Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis. Am J Clin Pathol 2010; 134: 826-834.
12. Bakin AV, Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 1999; 283: 387-390.
13. Bigey P, Ramchandani S, Theberge J, Araujo FD, Szyf M. Transcriptional regulation of the human DNA methyltransferase (dnmt1) gene. Gene 2000; 242: 407-418.
14. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y, Yuasa Y. Transcriptional regulation of the human DNA methyltransferase 3 A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 2005; 385: 557-564.
15. Kishikawa S, Murata T, Kimura H, Shiota K, Yokoyama KK. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. Eur J Biochem 2002; 269: 2961-2970.
16. Lin RK, Wang YC. Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer. Cell Biosci 2014; 4: 46.
17. Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 2000; 404: 1003-1007.
18. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416: 552-556.
19. Kufe D. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009; 9: 874-885.
20. Kufe D. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 2013; 32: 1073-1081.
21. Takahashi H, Jin C, Rajabi H, Pitroda S, Alam M, Ahmad R et al. MUC1-C activates the TAK1 inflammatory pathway in colon cancer. Oncogene 2015; 34: 5187-5197.
22. Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S et al. MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signaling. Nat Cell Biol 2007; 9: 1419-1427.
23. Ahmad R, Raina D, Joshi MD, Kawano T, Kharbanda S, Kufe D. MUC1-C oncoprotein functions as a direct activator of the NF-κB p65 transcription factor. Cancer Res 2009; 69: 7013-7021.
24. Rajabi H, Alam M, Takahashi H, Kharbanda A, Guha M, Ahmad R et al. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial mesenchymal transition. Oncogene 2014; 33: 1680-1689.
25. Alam M, Rajabi H, Ahmad R, Jin C, Kufe D. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells. Oncotarget 2014; 5: 2622-2634.
26. Raina D, Kosugi M, Ahmad R, Panchamoorthy G, Rajabi H, Alam M et al. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol Cancer Ther 2011; 10: 806-816.
27. Shen N, Yan F, Pang J, Wu LC, Al-Kali A, Litzow MR et al. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis. Oncotarget 2014; 5: 5494-5509.
28. Berger N, Ben Bassat H, Klein BY, Laskov R. Cytotoxicity of NF-kappaB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines. Exp Hematol 2007; 35: 1495-1509.
29. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32: e38.
30. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E et al. Analysis of repetitive element DNA methylation by Methy Light. Nucleic Acids Res 2005; 33: 6823-6836.
31. Lisanti S, Omar WA, Tomaszewski B, De Prins S, Jacobs G, Koppen G et al. Comparison of methods for quantification of global DNA methylation in human cells and tissues. PLoS ONE 2013; 8: e79044.
32. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31: 27-36.
33. De Carvalho DD, Sharma S, You JS, Su SF, Taberlay PC, Kelly TK et al. DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell 2012; 21: 655-667.
34. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
35. Rodic N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol 2014; 184: 1280-1286.
36. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 2010; 141: 1253-1261.
37. Tubio JM, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 2014; 345: 1251343.
38. Gnemmi V, Bouillez A, Gaudelot K, Hemon B, Ringot B, Pottier N et al. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/beta-catenin pathway and interaction with SNAIL promoter. Cancer Lett 2014; 346: 225-236.
39. Zrihan-Licht S, Weiss M, Keydar I, Wreschner DH. DNA methylation status of the MUC1 gene coding for a breast-cancer-associated protein. Int J Cancer 1995; 62: 245-251.
40. Yamada N, Nishida Y, Tsutsumida H, Hamada T, Goto M, Higashi M et al. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells. Cancer Res 2008; 68: 2708-2716.
41. Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L et al. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget 2016; 7: 11756-11769.